Engagement of Bone Morphogenetic Protein Type IB Receptor and Smad1 Signaling by Anti-Müllerian Hormone and Its Type II Receptor
Open Access
- 1 September 2000
- journal article
- Published by Elsevier BV
- Vol. 275 (36), 27973-27978
- https://doi.org/10.1074/jbc.m002704200
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Persistence of müllerian derivatives in malesAmerican Journal of Medical Genetics, 1999
- Specific Activation of Smad1 Signaling Pathways by the BMP7 Type I Receptor, ALK2Published by Elsevier BV ,1998
- TGF-β SIGNAL TRANSDUCTIONAnnual Review of Biochemistry, 1998
- A mouse Sertoli cell line expressing anti-Müllerian hormone and its type II receptorMolecular and Cellular Endocrinology, 1997
- Mutant Isoforms of the Anti-Müllerian Hormone Type II Receptor Are Not Expressed at the Cell MembranePublished by Elsevier BV ,1996
- Requirement for BMP Signaling in Interdigital Apoptosis and Scale FormationScience, 1996
- Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis.Genes & Development, 1995
- Insensitivity to anti–Müllerian hormone due to a mutation in the human anti–Müllerian hormone receptorNature Genetics, 1995
- Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects.The Journal of cell biology, 1995
- Mechanism of activation of the TGF-β receptorNature, 1994